Evidence map›Paper›PMID 40444372›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2025

Newly emerging metronidazole-resistant

Jaroslava Zikova, Klaudia Szarek, Monika Kabała, Dorota Wultańska, Natalia Frankowska, Adam Iwanicki, Krzysztof Hinc, Anna Mucha, Jolanta Komarnicka, Anna Jagielska and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. EmergingEmerging microbes & infections · 2025
    Article
  3. Review
  4. Dominance of toxigenicFrontiers in microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jaroslava ZikovaDepartment of Medical Microbiology, Charles University Second Faculty of Medicine and Motol University Hospital, Prague, Czechia.
Klaudia SzarekDepartment of Medical Microbiology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland.
Monika KabałaDepartment of Medical Microbiology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland.
Dorota WultańskaDepartment of Medical Microbiology, Medical University of Warsaw, Warsaw, Poland.
Natalia FrankowskaDivision of Molecular Bacteriology, Medical University of Gdańsk, Gdańsk, Poland.
Adam IwanickiDivision of Molecular Bacteriology, Medical University of Gdańsk, Gdańsk, Poland.
Krzysztof HincDivision of Molecular Bacteriology, Medical University of Gdańsk, Gdańsk, Poland.
Anna MuchaDepartment of Pulmonology with Oncology and Chemotherapy, Center of Pulmonology and Thoracic Surgery in Bystra, Poland.
Jolanta KomarnickaLaboratory of Clinical Microbiology, University Centre for Laboratory Diagnostics, Medical University of Gdańsk Clinical Centre, Gdańsk, Poland.
Anna JagielskaDepartment of Social Medicine and Public Health, Medical Faculty, Medical University of Warsaw, Warsaw, Poland.
Ed KuijperNational Expertise Centre for Clostridioides difficile infections, Leiden University Center for Infectious Diseases, Leiden and Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.
Marcela KrutovaDepartment of Medical Microbiology, Charles University Second Faculty of Medicine and Motol University Hospital, Prague, Czechia.
Hanna PituchDepartment of Medical Microbiology, Medical University of Warsaw, Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BackgroundOn 29 January 2024, the European Centre for Disease Prevention and Control distributed an alert about a metronidazole-resistant

Indexed as

Anti-Bacterial AgentsClostridioides difficileClostridium InfectionsDrug Resistance, BacterialMetronidazoleRibotypingCzech RepublicDisease OutbreaksHumansMicrobial Sensitivity TestsMultilocus Sequence TypingPolandPolymerase Chain ReactionSlovakiaWhole Genome SequencingAnti-Bacterial AgentsMetronidazoleaac(6')-aph(2”)ermBfluoroquinolonesheme-dependentLeu155IlenimBSurveillanceTyr130Ser

Identifiers

PMID40444372
PMCPMC12124108

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.